COMMUNIQUÉS West-GlobeNewswire

MacroGenics to Present at Deutsche Bank Health Care Conference
08/05/2018
ROCKVILLE, MD, May 07, 2018 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq: MGNX), a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal antibody-based therapeutics for [...]
Genesis Healthcare Expects to Release First Quarter 2018 Results on May 10, 2018
07/05/2018
KENNETT SQUARE, Pa., May 07, 2018 (GLOBE NEWSWIRE) -- Genesis HealthCare (NYSE: GEN ) (Genesis or the Company), one of the nation’s largest providers of post-acute care, today announced that it expects to release its [...]
Teligent, Inc. to Reschedule Conference Call for First Quarter 2018 Results
07/05/2018
BUENA, N.J., May 07, 2018 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT ), a New Jersey-based specialty generic pharmaceutical company, initially announced the Company would hold a conference call at 4:30pm ET on [...]
Atara Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
07/05/2018
SOUTH SAN FRANCISCO, Calif., May 07, 2018 (GLOBE NEWSWIRE) -- Atara Biotherapeutics, Inc. (Nasdaq: ATRA ), a leading off-the-shelf, allogeneic T-cell immunotherapy company developing novel treatments for patients with [...]
Amedisys Reports First Quarter 2018 Financial Results and Reaffirms 2018 Guidance
07/05/2018
BATON ROUGE, La., May 07, 2018 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED ) today reported its financial results for the three month period ended March 31, 2018. Three Month Periods Ended March 31, 2018 and 2017 [...]
Loxo Oncology Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
07/05/2018
STAMFORD, Conn., May 07, 2018 (GLOBE NEWSWIRE) -- Loxo Oncology, Inc. (Nasdaq: LOXO ), a biopharmaceutical company innovating the development of highly selective medicines for patients with genetically defined cancers, [...]
Forward Pharma Appeals the Decision of the Opposition Division to Revoke the EP2801355 Patent
07/05/2018
COPENHAGEN, Denmark, May 07, 2018 (GLOBE NEWSWIRE) -- Forward Pharma A/S (Nasdaq: FWP ) (“We” or “Forward” or the “Company”), today announced the filing of a notice of appeal of the decision of the Opposition Division [...]
Cytori to Webcast First Quarter Financial Results on May 10
07/05/2018
SAN DIEGO, May 07, 2018 (GLOBE NEWSWIRE) -- Cytori Therapeutics, Inc. (NASDAQ: CYTX ) will provide a live webcast of its first quarter financial results and business update on Thursday, May 10, 2018 at 5:30 PM Eastern [...]
Alliqua BioMedical, Inc. Announces Closing Asset Sale to Celularity Inc.
07/05/2018
Alliqua to return capital to shareholders Alliqua Retains H.C. Wainwright and Co. to evaluate strategic options LANGHORNE, Pa., May 07, 2018 (GLOBE NEWSWIRE) -- Alliqua BioMedical, Inc. (Nasdaq: ALQA ) ("Alliqua" or " [...]
Aeterna Zentaris Reports First Quarter 2018 Financial and Operating Results
07/05/2018
CHARLESTON, S.C., May 07, 2018 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc. (NASDAQ: AEZS ) (TSX: AEZS ) today reported financial and operating results for the first quarter ended March 31, 2018. All Amounts are in U.S. [...]
Agile Therapeutics Reports First Quarter 2018 Financial Results
07/05/2018
Current Business Plan Expected to Enable Cash to Fund Operations through the end of 2018 PRINCETON, N.J., May 07, 2018 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX ), a women's healthcare company, today [...]
Photocure ASA: Employee incentive program
07/05/2018
The board of directors of Photocure ASA resolved today a share capital increase as part of the employee long-term incentive program for restricted shares in the company. In addition, the board of directors resolved that [...]
Todd Wood joins Obalon Therapeutics, Inc. as Vice President Global Sales
07/05/2018
SAN DIEGO, May 07, 2018 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ: OBLN ), a vertically integrated medical technology company, announced today that Todd Wood has joined as Vice President Global Sales. Mr. [...]
Misonix Reports Record Third Quarter Revenue
07/05/2018
Revenue Rises 73% to $12.4 Million, Inclusive of $4.0 Million in Licensing Revenue, Resulting in Record Quarterly Diluted EPS of $0.23 FARMINGDALE, N.Y., May 07, 2018 (GLOBE NEWSWIRE) -- Misonix, Inc. (Nasdaq: MSON ) (“ [...]
Ultragenyx Reports First Quarter 2018 Financial Results and Corporate Update
07/05/2018
NOVATO, Calif., May 07, 2018 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE ), a biopharmaceutical company focused on the development of novel products for rare and ultra-rare diseases, today reported [...]
Ascendis Pharma A/S Announces Poster Presentation on TransCon PTH Phase 1 Trial at the European Congress of Endocrinology
07/05/2018
COPENHAGEN, Denmark, May 07, 2018 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND ), a biopharmaceutical company that utilizes its innovative TransCon technology to address significant unmet medical needs, today [...]
Fulgent Genetics Reports First Quarter 2018 Financial Results
07/05/2018
First Quarter 2018 Results : Revenue of $4.7 million, up 9% sequentially Billable tests delivered grew 10% sequentially to 4,621 GAAP loss of $1.9 million, or $0.11 per share Non-GAAP loss of $1.2 million, or $0.06 per [...]
Assembly Biosciences Announces First Quarter 2018 Financial Results
07/05/2018
INDIANAPOLIS and SAN FRANCISCO, May 07, 2018 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. (NASDAQ: ASMB ), a clinical-stage biotechnology company advancing a new class of oral therapeutics for the treatment of [...]
GBT Reports Recent Business Progress and First Quarter 2018 Financial Results
07/05/2018
SOUTH SAN FRANCISCO, Calif., May 07, 2018 (GLOBE NEWSWIRE) -- Global Blood Therapeutics, Inc. (GBT) (NASDAQ: GBT ) today reported recent business progress and financial results for the first quarter ended March 31, 2018 [...]

Pages